Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout. (2017)

First Author: Plumpton CO
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kex253

PubMed Identifier: 28957559

Publication URI: http://europepmc.org/abstract/MED/28957559

Type: Journal Article/Review

Volume: 56

Parent Publication: Rheumatology (Oxford, England)

Issue: 10

ISSN: 1462-0324